Palmitoyl Tetrapeptide-7
Lipopetide that mimics the effect of the natural immunomodulator thymosin β4 — reduces interleukin-6 levels (marker of inflammation and skin aging). Reduces chronic inflammation underlying photoaging and is the basis of the Matrixyl 3000 complex.
What is it?
Palmitoyl Tetrapeptide-7 — lipopetide: palmitic acid (C16) + tetrapeptide Gly-Gln-Pro-Arg. Molecular weight ~758 Da. Water-soluble (ionic form). Developed by Sederma (now Croda). Trade complex: Matrixyl 3000 = Palmitoyl Tripeptide-1 + Palmitoyl Tetrapeptide-7. Mechanism of action: the peptide sequence GQPR mimics a fragment of thymosin β4 and growth factor IGF-1 → signals cells to suppress pro-inflammatory cytokines. Clinically confirmed effect on reducing IL-6 and MMP (matrix metalloproteinases).
Anti-aging serums and creams (especially Matrixyl 3000 systems), products for mature and sensitive skin, means against photoaging and chronic inflammation.
Key Benefits
Suitable for
Main Actions
Matrixyl 3000 (Palmitoyl Tripeptide-1 + Palmitoyl Tetrapeptide-7): clinically effective concentration of each peptide — 0.005–0.02% in the finished product. Sederma recommends: 2–4% concentrate of Matrixyl 3000 in the product (in the concentrate ~0.5% of each peptide). Check the composition: if Palmitoyl Tetrapeptide-7 is listed before preservatives — the concentration is likely sufficient for effectiveness.
Check if this ingredient works for your skin — analyze your full product formula for free.
Analyze your product